383 filings
Page 3 of 20
8-K
gapzx
15 Sep 21
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development
4:36pm
SC 13G/A
om1xbjq 6l6
16 Feb 21
NANOVIRICIDES / CVI Investments ownership change
9:47am
SC 13G/A
c5mm ycyjg2zc5
12 Feb 21
NANOVIRICIDES / Altium Capital Management ownership change
12:00am
SC 13G/A
dztt gby3
26 Jan 21
NANOVIRICIDES / Empery Asset Management ownership change
11:04am
SC 13G/A
sfttqi ec08
4 Jan 21
NANOVIRICIDES / SABBY MANAGEMENT ownership change
11:44am
8-K
igspf jz2i
10 Dec 20
Submission of Matters to a Vote of Security Holders
4:30pm
424B5
gnnksjsvhekc
3 Dec 20
Prospectus supplement for primary offering
4:30pm
8-K
0t2u0zmicya i5h4m7
19 Nov 20
NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA
4:53pm
NT 10-K
9jjg z1vd
28 Sep 20
Notice of late annual filing
4:30pm
8-K
z8wbcgrb9o
4 Sep 20
NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference
4:05pm
8-K
bja udv0cp
3 Aug 20
Entry into a Material Definitive Agreement
5:19pm
424B5
8son3
31 Jul 20
Prospectus supplement for primary offering
5:29pm
SC 13G
wu2gk0kq pwatw
20 Jul 20
NANOVIRICIDES / Altium Capital Management ownership change
3:29pm
8-K
1wl6j6um2t
13 Jul 20
Nanoviricides Closes on $11.5 Million Underwritten Public Offering of Common Stock
4:52pm
424B5
wuujbg lhr6wosstyv46
9 Jul 20
Prospectus supplement for primary offering
5:13pm